Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
Frequently asked questions
What sector does Bloomios Inc (BLMS) operate in?
Bloomios Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Bloomios Inc (BLMS) current stock price?
As of the latest data, Bloomios Inc stock price is $0.00, with a previous close of $0.00.
What is Bloomios Inc (BLMS) current market capitalization?
Bloomios Inc market cap is approximately 19.34 thousand.
What is Bloomios Inc (BLMS) Earnings Per Share (EPS)?
The trailing EPS is -$5.73.
Does Bloomios Inc (BLMS) pay dividends?
No. Bloomios Inc does not pay a dividend.
What is Bloomios Inc (BLMS) beta (volatility) score?
Bloomios Inc has a beta of -0.453, indicating lower volatility than the overall market.